Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB
about
11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Common Alzheimer's disease risk variant within the CLU gene affects white matter microstructure in young adultsToward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAmyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET ImagingThe relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associationsUshering in the study and treatment of preclinical Alzheimer diseaseMild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's diseaseFunctional network endophenotypes unravel the effects of apolipoprotein E epsilon 4 in middle-aged adultsAssociation of Longitudinal Cognitive Decline With Amyloid Burden in Middle-aged and Older Adults: Evidence for a Dose-Response Relationship.Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches.Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia.Spatiotemporal linear mixed effects modeling for the mass-univariate analysis of longitudinal neuroimage data.Statistical analysis of longitudinal neuroimage data with Linear Mixed Effects models.Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.Self-reported confusion is related to global and regional β-amyloid: data from the Women's healthy ageing project.Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage.Cerebral Blood Flow and Amyloid-β Interact to Affect Memory Performance in Cognitively Normal Older Adults.Diagnosis and biomarkers of predementia in Alzheimer's disease.In vivo human amyloid imaging.Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function?Amyloid burden, neuronal function, and cognitive decline in middle-aged adults at risk for Alzheimer's diseaseBrain imaging in the study of Alzheimer's diseaseRelationship between memory performance and β-amyloid deposition at different stages of Alzheimer's disease.JointMMCC: joint maximum-margin classification and clustering of imaging data.Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's diseaseShould we disclose amyloid imaging results to cognitively normal individuals?Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults.Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study.The preclinical Alzheimer cognitive composite: measuring amyloid-related declineBiomarkers and cognitive endpoints to optimize trials in Alzheimer's disease.Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 2Neural correlates of the interactive relationship between memory deficits and depressive symptoms in nondemented elderly: resting fMRI study.The evolution of preclinical Alzheimer's disease: implications for prevention trials.Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriersSynergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals.Depressive symptoms, brain volumes and subclinical cerebrovascular disease in postmenopausal women: the Women's Health Initiative MRI Study.Amyloid imaging and memory change for prediction of cognitive impairment.Age and amyloid-related alterations in default network habituation to stimulus repetition.Amyloid-β associated cortical thinning in clinically normal elderly.Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals.
P2860
Q24194742-E31BE385-5BD7-4AA3-8BD1-7C2917C42EB4Q24301468-19CF333A-3C97-4EF6-8955-32637A4A2EFFQ24595802-49B63350-DF67-4318-9454-3A155F77FDC7Q26750249-903F2C0A-8D84-4E1F-831A-9B2FAD0F9064Q26830467-8649F21F-56F0-45AF-9CB6-48FA389A1890Q27014791-95CFA9A3-0E8C-42CC-8576-6805F38091A0Q27027319-C3A20088-5678-4960-B437-EA30E3B09CFFQ28394313-ED979F33-73D6-4981-8D04-6E1C4F277D63Q30101023-19F8AB88-E334-4C27-8503-3CA26B21B715Q30413572-E7641D97-627F-4BC0-8407-719CA5CF8097Q30413904-72A1F543-3840-4758-957C-41A25553F836Q30486156-8E7C356C-A64C-4FFB-9CA8-72E776864E4FQ30576007-775EF6E7-1EB7-40B8-9D29-22E3A03CFF45Q30996727-9C8E10A1-D4F0-4DF0-A1E6-01C083492B5FQ31155701-1A27DEB2-32C0-4237-B192-5480A75C352DQ33581237-FE59301F-51CF-43F6-8224-99E9B9E5EB33Q33775095-995CC2B6-3614-4701-99DD-E73E408535FDQ33777509-DC711F02-E366-4C16-AA30-726371DC23F9Q33790277-A24F181D-4AB0-4706-9C5C-3F58D234B842Q33872248-6B442A91-1658-4AE1-8F34-468A6F0AE293Q33920450-BDF00CC2-8264-4278-AB37-E344589D71ECQ34102331-B03EC8C4-1F13-464D-A00B-2A56F11B463BQ34149444-0625B157-316B-4530-A920-502196ABB955Q34157017-7ABC9B12-180F-49D3-8D72-E7B21B38F203Q34247849-14A5153C-D44F-43BE-9C57-F00751B37F76Q34286140-2581349B-6902-4C0C-8EDE-2F0FBCD70613Q34311853-2DE65D79-872B-4BED-AE86-3F593C7F1184Q34333511-5A0BFCF7-8C95-4A2F-A128-69B382960FEAQ34422469-A12DC673-4660-44C0-944F-EE08F90A7DEBQ34477459-4BAB2726-DB79-4170-8094-B176CC538EDAQ34551727-0427296D-2FAF-4627-968F-88239334DDD6Q34709193-DD8B39EB-A775-4CB3-8A93-7C3E77A3DC40Q34849048-EA20F469-C5A5-40F8-8747-933031227D1EQ34922644-BEFD6BD0-198A-46AF-907E-AC42A2271211Q34940642-CB4BF412-68BC-4F00-A7D4-AEC06FEB20C8Q35028141-A1A9F618-D37C-44AB-983E-F2281719A204Q35029095-74E1F1A4-B3ED-45A9-BFD1-B6B34DB64914Q35036823-AEE184DD-E7DB-4825-BB06-7CC7A5B6467AQ35053524-DA87F66E-C183-4084-A2B1-44B07A5662E6Q35076119-04F430FD-5E97-4DA0-8457-DF04956E5122
P2860
Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Longitudinal cognitive decline ...... loid-beta measured by [11C]PiB
@ast
Longitudinal cognitive decline ...... loid-beta measured by [11C]PiB
@en
type
label
Longitudinal cognitive decline ...... loid-beta measured by [11C]PiB
@ast
Longitudinal cognitive decline ...... loid-beta measured by [11C]PiB
@en
prefLabel
Longitudinal cognitive decline ...... loid-beta measured by [11C]PiB
@ast
Longitudinal cognitive decline ...... loid-beta measured by [11C]PiB
@en
P2093
P2860
P1433
P1476
Longitudinal cognitive decline ...... loid-beta measured by [11C]PiB
@en
P2093
C A Mathis
L Ferrucci
R F Dannals
S M Resnick
P2860
P304
P356
10.1212/WNL.0B013E3181D3E3E9
P407
P577
2010-02-10T00:00:00Z